1. Home
  2. AVDL vs REAX Comparison

AVDL vs REAX Comparison

Compare AVDL & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

N/A

Current Price

$21.42

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Logo The Real Brokerage Inc.

REAX

The Real Brokerage Inc.

N/A

Current Price

$3.83

Market Cap

790.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AVDL
REAX
Founded
2015
2018
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
790.0M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
AVDL
REAX
Price
$21.42
$3.83
Analyst Decision
Buy
Strong Buy
Analyst Count
9
3
Target Price
$18.38
$6.33
AVG Volume (30 Days)
2.1M
1.4M
Earning Date
11-04-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$248,517,000.00
$1,813,907,000.00
Revenue This Year
$65.47
$56.57
Revenue Next Year
$30.88
$21.77
P/E Ratio
N/A
N/A
Revenue Growth
79.88
65.60
52 Week Low
$6.38
$3.42
52 Week High
$23.57
$5.65

Technical Indicators

Market Signals
Indicator
AVDL
REAX
Relative Strength Index (RSI) 59.08 46.10
Support Level $21.36 $3.92
Resistance Level $21.45 $4.50
Average True Range (ATR) 0.11 0.16
MACD -0.21 0.00
Stochastic Oscillator 40.30 12.99

Price Performance

Historical Comparison
AVDL
REAX

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

Share on Social Networks: